insights_auto
Why is 2U3 up 2,34%?
Dive Deeperchevron_right
2U3:FRA
Alcon
56,92 €
arrow_upward
+2,34%(+1,30) 1D
9 հոկ, 22:00:00 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2U3...
Open
56,38 €
High
56,92 €
Low
56,38 €
Mkt. cap
26,50 մլրդ
Avg. vol.
138,00
Volume
303,00
52-wk high
73,96 €
52-wk low
51,78 €
No. of employees
25 հզր
Open
56,38 €
High
56,92 €
Low
56,38 €
Mkt. cap
26,50 մլրդ
Avg. vol.
138,00
Volume
303,00
52-wk high
73,96 €
52-wk low
51,78 €
No. of employees
25 հզր
News stories
From web sources and news partners
Simply Wall Street
·
20 ժամ առաջ
What Alcon Shares Launch Of New Dry Eye Drops In Canada Means For Shareholders
ad-hoc-news.de
·
23 ժամ առաջ
Alcon stock is unchanged at EUR 57.25 as AAO 2026 begins
AD HOC NEWS
·
1 օր առաջ
Alcon stock trades at EUR 57.02 with CHF 25.9 billion market value
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
Sector-
Websitealcon.com